Literature DB >> 26319147

Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship.

M Noni1, A Katelari2, G Dimopoulos3, S-E Doudounakis2, C Tzoumaka-Bakoula4, V Spoulou5.   

Abstract

Aspergillus fumigatus is commonly found in cystic fibrosis (CF) airways. Our aim was to assess the relationship between A. fumigatus chronic colonization and lung function in CF patients. A case-control study of CF patients born from 1989 to 2002 was performed. Medical records were reviewed from the time of initial diagnosis until December 2013. Chronic colonization was defined as two or more positive sputum cultures in a given year. Each patient chronically colonized with A. fumigatus was matched with three control patients (never colonized by A. fumigatus) for age, sex, and year of birth (±3 years). A number of parameters were recorded and analyzed prospectively. The primary outcome measure was the difference in forced expiratory volume in 1 s (FEV1) in percent predicted between groups. Linear mixed models were used for longitudinal analyses to evaluate the relationship between A. fumigatus chronic colonization and lung function during a 7-year period and study the lung function 4 years before the time of enrollment (t0). Twenty patients had chronic colonization and were matched with 60 controls. A significant difference in lung function was detected throughout the 7-year period after adjustment for confounders (est = 8.66, p = 0.020). Four years before t0, FEV1 baseline was the only factor associated with the course of lung function (est = 0.64, p < 0.001) and was significantly different between groups (p = 0.001). In conclusion, a decreased FEV1 baseline appears to be a risk factor for chronic colonization by A. fumigatus, which, in turn, may cause a faster deterioration of lung function.

Entities:  

Mesh:

Year:  2015        PMID: 26319147     DOI: 10.1007/s10096-015-2474-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  33 in total

Review 1.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

2.  The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.

Authors:  Reshma Amin; Annie Dupuis; Shawn D Aaron; Felix Ratjen
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

3.  Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis.

Authors:  P E Verweij; J F Meis; J Sarfati; J A Hoogkamp-Korstanje; J P Latgé; W J Melchers
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis.

Authors:  Virginie Jubin; Stéphane Ranque; Nathalie Stremler Le Bel; Jacques Sarles; Jean-Christophe Dubus
Journal:  Pediatr Pulmonol       Date:  2010-08

5.  Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?

Authors:  A M M de Vrankrijker; C K van der Ent; F T van Berkhout; R K Stellato; R J L Willems; M J M Bonten; T F W Wolfs
Journal:  Clin Microbiol Infect       Date:  2010-12-16       Impact factor: 8.067

6.  Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients.

Authors:  J Bargon; N Dauletbaev; B Köhler; M Wolf; H G Posselt; T O Wagner
Journal:  Respir Med       Date:  1999-11       Impact factor: 3.415

7.  Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France.

Authors:  André Paugam; Marie-Thérèse Baixench; Nadine Demazes-Dufeu; Pierre-Régis Burgel; Elise Sauter; Reem Kanaan; Daniel Dusser; Jean Dupouy-Camet; Dominique Hubert
Journal:  Med Mycol       Date:  2010-11       Impact factor: 4.076

8.  A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.

Authors:  M E Hodson; C G Gallagher; J R W Govan
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

9.  Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis.

Authors:  Christopher R Sudfeld; Elliott C Dasenbrook; William G Merz; Karen C Carroll; Michael P Boyle
Journal:  J Cyst Fibros       Date:  2009-12-31       Impact factor: 5.482

Review 10.  Aspergillus-associated airway disease, inflammation, and the innate immune response.

Authors:  Sanjay H Chotirmall; Mazen Al-Alawi; Bojana Mirkovic; Gillian Lavelle; P Mark Logan; Catherine M Greene; Noel G McElvaney
Journal:  Biomed Res Int       Date:  2013-07-21       Impact factor: 3.411

View more
  18 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis.

Authors:  Gina Hong; Kevin Alby; Sharon C W Ng; Victoria Fleck; Christina Kubrak; Ronald C Rubenstein; Daniel J Dorgan; Steven M Kawut; Denis Hadjiliadis
Journal:  J Cyst Fibros       Date:  2019-08-21       Impact factor: 5.482

3.  Aspergillus Bronchitis in Patients with Cystic Fibrosis.

Authors:  Claudia Brandt; Jobst Roehmel; Volker Rickerts; Volker Melichar; Nadja Niemann; Carsten Schwarz
Journal:  Mycopathologia       Date:  2017-08-17       Impact factor: 2.574

4.  Use of Selective Fungal Culture Media Increases Rates of Detection of Fungi in the Respiratory Tract of Cystic Fibrosis Patients.

Authors:  Gina Hong; Heather B Miller; Sarah Allgood; Richard Lee; Noah Lechtzin; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

5.  Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis.

Authors:  Gina Hong; Kevin J Psoter; Mark T Jennings; Christian A Merlo; Michael P Boyle; Denis Hadjiliadis; Steven M Kawut; Noah Lechtzin
Journal:  J Cyst Fibros       Date:  2018-02-12       Impact factor: 5.482

Review 6.  Progress and challenges in fungal lung disease in cystic fibrosis.

Authors:  Gina Hong
Journal:  Curr Opin Pulm Med       Date:  2022-09-19       Impact factor: 2.868

7.  Clinical Impact of Aspergillus fumigatus in Children with Cystic Fibrosis.

Authors:  Valentina Fainardi; Chiara Sodini; Michela Deolmi; Andrea Ciuni; Kaltra Skenderaj; Maria Bice Stabile; Cosimo Neglia; Elena Mariotti Zani; Cinzia Spaggiari; Nicola Sverzellati; Susanna Esposito; Giovanna Pisi
Journal:  Microorganisms       Date:  2022-03-29

Review 8.  Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.

Authors:  Jean Tyrrell; Máire Callaghan
Journal:  Microbiology (Reading)       Date:  2015-12-04       Impact factor: 2.777

Review 9.  Emerging Fungal Threats in Cystic Fibrosis.

Authors:  C Schwarz; P Eschenhagen; J P Bouchara
Journal:  Mycopathologia       Date:  2021-07-28       Impact factor: 2.574

Review 10.  Pathogenesis of Fungal Infections in Cystic Fibrosis.

Authors:  Craig Williams; Ranjith Ranjendran; Gordon Ramage
Journal:  Curr Fungal Infect Rep       Date:  2016-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.